“’As soon as possible!’ – Development of biomarkers to identify dementia.”

presented by:

Charlotte E. Teunissen, PhD

Professor in Neurochemistry, Chair of the Neurochemistry lab, Amsterdam UMC, Netherlands.

Dr. Charlotte Teunissen aims to improve care of patients with neurological diseases by developing body fluid biomarkers for diagnosis, stratification, prognosis and monitoring treatment responses. Studies of her research group span the entire spectrum of biomarker development, starting with biomarker identification, followed by assay development and validation, and extensive clinical validation to ultimately implement novel biomarkers in clinical practice. She is responsible for the Alzheimer Center Amsterdam body fluid and leads several international biomarker networks, such as the CSF Society and the Alzheimer Association-Global Biomarker Standardization consortium, and the recently founded Coral proteomics consortium. She is the coordinator of the Marie Curie MIRIADE project, aiming to train 15 novel researchers into accelerate dementia biomarker development.

Hosted by Dr. Mony J. de Leon